Inactive Instrument

Wockhardt Bio AG

WBIO

CH0193042501

Wockhardt Bio AG Avails Secure Term Loan of $250 Million Facility

July 01, 2016 at 12:56 pm

Wockhardt Ltd. announced that the company has given Corporate Guarantee to secure Term loan of $250 Million facility availed by Wockhardt Bio AG, a subsidiary of the company.

Latest news about Wockhardt Bio AG

Wockhardt Bio AG Reports Earnings Results for the Full Year Ended March 31, 2022	12/07/22	CI
Wockhardt Bio Ag and Jiangxi Jemincare Group Company Limited, China ("Jemincare"), Partnered for Wockhardt's Novel Patented Antibiotic Wck 4873	26/08/21	CI
Wockhardt Bio AG Reports Earnings Results for the Full Year Ended March 31, 2021	07/06/21	CI
Wockhardt Bio AG Announces Audited Earnings Results for the Year Ended March 31, 2020	05/07/20	CI
Wockhardt Ltd. cancelled the acquisition of Wockhardt France S.A.S. from Wockhardt Bio AG.	09/11/17	CI
Wockhardt Ltd. agreed to acquire Wockhardt France S.A.S. from Wockhardt Bio AG.	09/11/16	CI
Wockhardt Bio AG Avails Secure Term Loan of $250 Million Facility	01/07/16	CI
Wockhardt Bio AG has completed an IPO in the amount of CHF 11.8574 million.	18/12/13	CI

Wockhardt Bio AG is a Germany-based pharmaceutical company. It is active in the development, manufacturing and marketing of pharmaceutical and biopharmaceutical formulations. It offers a portfolio of generic drugs, which includes approximately 600 pharmaceuticals in various dosages and forms. Its offering covers several therapeutic categories, such as central nervous system agents, hormones, cardiovascular agents, anti-infective and respiratory agents, as well as gastrointestinal, dermatological and biological agents. The Company supplies markets in the United States, the United Kingdom, Ireland, France and Latin America. Additionally, it exports its pharmaceutical products to over 50 countries.

Sector

Pharmaceuticals

More about the company

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+22.69%	43.81B
OTSUKA HOLDINGS CO., LTD.	+25.56%	23.01B
SANDOZ GROUP AG	+18.00%	15.27B
CIPLA LIMITED	+8.91%	13.68B
ZYDUS LIFESCIENCES LIMITED	+42.72%	11.96B
ONO PHARMACEUTICAL CO., LTD.	-7.49%	6.98B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+12.22%	5.59B

Generic Pharmaceuticals